EGFR and synovial sarcoma: The reports about EGFR upregulation in SS have not indicated any direct interaction or association with the SS18-SSX1 or SS18-SSX2 fusion proteins which might explain why inhibition of EGFR pathway was not successful in SS treatment [122, 126].